Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Carcinoma, Hepatocellular 14Carcinoma, Non-Small-Cell Lung 9Colorectal Neoplasms 7Stomach Neoplasms 6Triple Negative Breast Neoplasms 5Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Neoplasms 3Melanoma 3Urinary Bladder Neoplasms 2Recurrence 2Rectal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Extranodal NK-T-Cell 2Liver Neoplasms 2Glioblastoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Advanced Biliary Tract Cancer 2Urothelial Carcinoma Bladder 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Radiation Pneumonitis 1

Interventions

pegaspargase 14Etoposide 11Dexamethasone 11Gemcitabine 10spartalizumab 6Oxaliplatin 4sintilimab 3Radiotherapy 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Methotrexate 3Asparaginase 3tislelizumab 2camrelizumab 2Lenalidomide 2Drug Therapy 2Cyclophosphamide 2Cisplatin 2Busulfan 2Azacitidine 2toripalimab 1tofacitinib 1ruxolitinib 1romidepsin 1pembrolizumab 1fludarabine phosphate 1avelumab 1apatinib 1Thalidomide 1Sensitivity and Specificity 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Extranodal NK-T-Cell × tislelizumab × Clear all
NCT05254899 2022-02-24

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

ChineseAMS

Phase 2 Unknown
54 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT04899414 2021-05-24

Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma

Peking University

Phase 2 Unknown
50 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡